Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Dynavax Technologies Corporation (DVAX) will present at the 6th Annual Evercore ISI HealthCONx Conference on November 28. The company, a biopharmaceutical firm focusing on innovative vaccines, will webcast the presentation accessible through its Investors website section.

EMERYVILLE, Calif., Nov. 20, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28 at 4:40 p.m. ET.

The presentation will be webcast and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at https://investors.dynavax.com/events-presentations.

About Dynavax

Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B^® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S., the European Union and Great Britain for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older, and CpG 1018^® adjuvant, currently used in multiple adjuvanted COVID-19 vaccines. Dynavax is advancing CpG 1018 adjuvant as a premier vaccine adjuvant with adjuvanted vaccine clinical programs for shingles and Tdap, and through global collaborations, currently focused on adjuvanted vaccines for COVID-19, plague, seasonal influenza and universal influenza. For more information about our marketed products and development pipeline, visit www.dynavax.com and follow Dynavax on LinkedIn and Twitter.

For Investors/Media:
Paul Cox
pcox@dynavax.com
510-665-0499

Nicole Arndt
narndt@dynavax.com
510-665-7264

View original content to download multimedia:https://www.prnewswire.com/news-releases/dynavax-to-present-at-the-6th-annual-evercore-isi-healthconx-conference-301994068.html

SOURCE Dynavax Technologies

FAQ

When will Dynavax Technologies Corporation present at the 6th Annual Evercore ISI HealthCONx Conference?

Dynavax Technologies Corporation will present at the 6th Annual Evercore ISI HealthCONx Conference on November 28 at 4:40 p.m. ET.

What is the focus of Dynavax Technologies Corporation?

Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines.

How can the presentation be accessed?

The presentation will be webcast and may be accessed through the 'Events & Presentations' page on the 'Investors' section of the Company's website at https://investors.dynavax.com/events-presentations.